Substance: Lopinavir, Ritonavir
Pack: 1 bottle (60 tabs/bottle)
Lopinavir and Cipla’s LOPIMUNE – can HIV drugs treat coronavirus infection?
An HIV protease inhibitor, lopinavir is being studied along with ritonavir for the treatment of coronaviruses. The repurposed drug is already approved for the treatment of HIV infection. The combination is listed in the WHO list of essential medicines. Lopinavir is believed to act on the intracellular processes of coronavirus replication and demonstrated reduced mortality.
Cipla is also reportedly planning to repurpose its HIV drug LOPIMUNE, which is a combination of protease inhibitors Lopinavir and Ritonavir, for the treatment of coronavirus.
LOPIMUNE is currently available in packs of 60 tablets each, containing 200mg of Lopinavir and 50mg of Ritonavir.
What are the symptoms?
Coronavirus symptoms include those associated with common cold, such as running nose, headache, cough, fever, and sore throat.
Much is unknown about how 2019-nCoV, a new coronavirus, spreads. Current knowledge is largely based on what is known about similar coronaviruses. Coronaviruses are a large family of viruses that are common in many different species of animals, including camels, cattle, cats, and bats. Rarely, animal coronaviruses can infect people and then spread between people such as with MERS, SARS, and now with 2019-nCoV Most often, spread from person-to-person happens among close contacts. Person-to-person spread is thought to occur mainly via respiratory droplets produced when an infected person coughs or sneezes, similar to how influenza and other respiratory pathogens spread. These droplets can land in the mouths or noses of people who are nearby or possibly be inhaled into the lungs. It’s currently unclear if a person can get 2019-nCoV by touching a surface or object that has the virus on it and then touching their own mouth, nose, or possibly their eyes.
No reviews found
Please log in to write review.